Mexiletine dosing and tolerability in refractory chronic migraine: Insights from post-lidocaine infusion treatment
Background Mexiletine is used as a preventive medication for refractory chronic migraine (rCM) and to prolong migraine improvement following intravenous lidocaine infusion. However, published evidence supporting its use in migraine remains limited. This retrospective study describes the dosing, trea...
Saved in:
Main Authors: | Lucia Liao, Hsiangkuo Yuan, Dylan Selbst, Emily Casaletto, Jiangang Liao, Clinton G. Lauritsen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Cephalalgia Reports |
Online Access: | https://doi.org/10.1177/25158163241313123 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of Interventional Therapies for Refractory Pediatric Migraine
by: Jacquelin Peck, et al.
Published: (2023-01-01) -
Efficacy of continuous intravenous infusion of lidocaine on postoperative sore throat after laryngeal mask insertion: a randomized controlled trial
by: Jianxin Jiang, et al.
Published: (2025-02-01) -
Rimegepant for the treatment of migraine
by: Amnon A. Berger, et al.
Published: (2022-10-01) -
Lidocaine Versus Ketamine Pretreatment on Propofol Injection Pain
by: Amir Murad Khudadad Boujan, et al.
Published: (2019-12-01) -
Resolution of Refractory Status Epilepticus With Ketamine Without Intubation in a Patient With Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome
by: Kyle N. Kaneko, et al.
Published: (2025-01-01)